Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Experts recommend consistency for 812 weeks, combining with gentle exfoliation
Enfortumab vedotin (EV) as monotherapy in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Results of stage I of a phase 2 trial
Collagen electrophoresis can be used to study the effect of the variant but the absence of demonstration of abnormal collagen III produced by fibroblasts does not exclude the diagnosis
(2021) established a CKD rat model using the 5/6 Nx and an adenine-containing diet to investigate the efficacy of JPYSF in treating CKD and to explore its potential mechanisms
US$ 21.75
US$ 23.92
US$ 24.90
US$ 28.11
US$ 29.23
